Healthcare

What Are the Details Behind Opthea Limited's New ASX Quotation?
February 21, 2025 06:36 PM AEDT| By Team Kalkine MediaHeadlines,Update on the application for a new securities quotation on the Australian exchange,Issuance derived from the exercise of options and conversion of convertible instruments,Corporate structural adjustments unfolding within the healthcare and...

Telix Pharmaceuticals' (ASX:TLX) Shares Surge on Strong Full-Year Profit Growth
February 21, 2025 01:56 PM AEDT| By Team Kalkine MediaHighlights,Telix,Pharmaceuticals (TLX) posts a tenfold increase in full-year profit.,The stock climbs over 13% following the announcement.,Shares have gained more than 170% over the past year.,Telix Pharmaceuticals (ASX:TLX) experienced a significant...

Mayne Pharma Backs $672 Million Takeover Offer from Cosette Pharma
February 21, 2025 01:51 PM AEDT| By Team Kalkine MediaHighlights,Mayne Pharma (,ASX:MYX,) receives a $7.40 per share acquisition offer from Cosette Pharma.,The deal,represents,a 37% premium to Mayne Pharma’s last closing price.,The acquisition expands Cosette Pharma’s portfolio and global presence in wo...

Telix Pharmaceuticals: Revenue Up 56%, Profit Jumps 860%, and More Growth Expected in FY 2025
February 21, 2025 11:13 AM AEDT| By Team Kalkine MediaKey Highlights:,Record High Share Price:,Telix shares hit,$30.00,, up,13%,on Friday morning.,Revenue Growth:,Revenue surged,56% to $783.2 million,, beating expectations.,Profit Explosion:,Profit after tax,soared 860% to $49.9 million,.,Strong FY 2025...

ASX Healthcare Sector: Market Resilience and Key Developments
February 21, 2025 11:00 AM AEDT| By Team Kalkine MediaASX Healthcare Sector: Market Resilience and Key Developments

Healius Navigates Turnaround Plan with Pathology Growth Amid Short-Term Challenges (ASX:HLS)
February 20, 2025 02:40 PM AEDT| By Team Kalkine MediaHighlights,Reports,$12.8 million net loss,amid business,restructuring,.,Revenue jumps 10%,to $933.9 million, with strong pathology growth.,Plans,special dividend,after debt refinancing.,Healius (ASX:HLS), Australia's second-largest pathology group, h...

Is Vitura Health Overlooked in Australia’s Pharmaceuticals Market?
February 20, 2025 11:30 AM AEDT| By Team Kalkine MediaHighlights:,Shares have rebounded in recent weeks despite a steep decline over the previous year.,The price‐to‐sales metric remains considerably lower than that of many industry peers.,Revenue expansion has been moderate relative to the broader perfo...

Neurotech International Gains Key Regulatory Support for Rett Syndrome Drug
February 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,(ASX:NTI) secures a positive opinion from the European Medicines Agency for NTI164’s Orphan Medicinal Product Designation.,The US FDA granted orphan drug status to NTI164 in late 2024, signaling progress for the treatment’s potential appro...

Cochlear's (ASX:COH) Market Moves: Why This Healthcare Stock is on the Radar
February 20, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Cochlear (COH) stock has seen a 5.3% dip in 2025, drawing investor attention.,The healthcare sector remains a stable revenue generator, even during economic downturns.,Cochlear’s long-term growth outlook benefits from rising global healthc...

CardieX Limited Navigating the Path to Profitability
February 19, 2025 03:33 PM AEDT| By Team Kalkine MediaCardieX Limited Navigating the Path to Profitability

Fast-Track Approval Boosts Clarity Pharmaceuticals' Prostate Cancer Breakthrough
February 19, 2025 03:08 PM AEDT| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals secures fast-track approval for its prostate cancer drug.,The FDA’s decision accelerates development and market entry.,Cu-SAR-,bisPSMA,aims to enhance treatment options for advanced prostate cancer.,Clarity Pharmace...

Imagion Biosystems Moves Forward with FDA Application for MagSense HER2 Imaging Agent
February 19, 2025 02:09 PM AEDT| By Team Kalkine MediaHighlights,Imagion,Biosystems (IBX) progresses with FDA application for its,MagSense,HER2 imaging agent.,Phase 2 study aims to,optimize,dose and imaging protocol for improved diagnostic accuracy.,Recent capital funding of $3 million supports the next...

Will Clarity Pharmaceuticals' Imaging Agent Change Prostate Cancer Detection?
February 19, 2025 01:31 PM AEDT| By Team Kalkine MediaHighlights,FDA fast-track designation for prostate cancer imaging agent.,Innovation in dual-targeted bisPSMA technology developed in Australian laboratories.,Elevated market activity observed in the Australian biotech sector.,The biotechnology field...

Why Cyclopharm's (ASX:CYC) Cash Burn Isn't a Major Concern for Us
February 19, 2025 11:32 AM AEDT| By Team Kalkine MediaHighlights,Cyclopharm's cash reserves suggest a stable runway for growth.,Analyst forecasts indicate potential for cashflow breakeven soon.,Market capitalization analysis hints at feasible fundraising strategies.,Investors often find that even in cha...

Biocurious: As Mayne Pharmaceuticals faces a takeover bid, who might be next?
February 19, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Acquisition Momentum:,The agreement for Mayne Pharma to be acquired by Cosette has brought attention to the broader ASX biotech space, highlighting increased interest from global pharmaceutical companies.,Historical Perspective:,Previous...

How Are ASX-Listed Healthcare Companies Advancing Cancer Diagnostics and Treatments?
February 19, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Imagion Biosystems is leading the charge in cancer diagnostics with its MagSense platform for HER2+ breast cancer.,Noxopharm focuses on innovative treatments for glioblastoma through its Chroma platform.,Amplia and Invion are pioneering c...

Little Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation in the Pharmaceuticals Sector
February 18, 2025 01:33 PM AEDT| By Team Kalkine MediaLittle Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation in the Pharmaceuticals Sector

HMC Capital Considers Healthscope Acquisition with Focus on Workforce Stability
February 18, 2025 12:04 PM AEDT| By Team Kalkine MediaHighlights:,HMC Capital explores a potential acquisition of Healthscope, aiming to,maintain,operational stability.,The company,seeks,to minimise facility closures and job reductions as part of the deal.,HealthCo,Healthcare & Wellness REIT,discloses,d...

Health Check: Brokers Reduce Cochlear Valuations as Customers Delay Product Upgrades
February 18, 2025 11:00 AM AEDT| By Team Kalkine MediaBiotech Industry Update: Key Developments and Trials

Health Check: It's Time to Showcase Our Three Local Heroes
February 18, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Nanosonics prepares to introduce Coris, a new anti-infection device designed for hospital instrument cleaning.,Cogstate experiences revenue growth, driven by advancements in Alzheimer's disease clinical trials.,Sonic Healthcare reports pr...

Advertise your brand on Kalkine Media